Chemical structure of cetirizine
Find information on thousands of medical conditions and prescription drugs.

Zyrtec

Cetirizine hydrochloride is a medication used for the treatment of allergies, hay fever, angioedema, and hives. It is a second-generation H1-receptor antagonist antihistamine and works by blocking H1 histamine receptors. It is a major metabolite of hydroxyzine, and has the same basic side effects, including dry mouth. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Zafirlukast
Zagam
Zalcitabine
Zaleplon
Zanaflex
Zanamivir
Zantac
Zarontin
Zelnorm
Zerit
Zestoretic
Zestril
Zetia
Zevalin
Ziagen
Zidovudine
Zileuton
Ziprasidone
Zithromax
Zocor
Zofran
Zoladex
Zoledronic acid
Zolmitriptan
Zoloft
Zolpidem
Zometa
Zomig
Zonegran
Zonisamide
Zopiclone
Zosyn
Zovia
Zovirax
Zyban
Zymar
Zyprexa
Zyrtec
Zyvox
  • It has long duration of action
  • No reported cardiac toxicity associated with the use of this drug
  • Minimal penetration of the blood-brain barrier
  • Only mild sedating effects, although more than some other non-sedating antihistamines

The medication is produced by UCB, a Belgian pharmaceutical company. The drug is marketed under the following brand names: Zyrtec® in the USA, Zirtek® in the United Kingdom, Zyrlex® in many other European countries, Reactine® in Canada (all by Pfizer ), and as Virlix® in Mexico and parts of Europe (by GlaxoSmithKline ). It can be found under a variety of other brand names in other countries .

Like many other antihistamine medications, cetirizine is commonly prescribed in combination with pseudoephedrine hydrochloride, a decongestant. These combinations are marketed using the same brand name as the cetirizine with a "-D" suffix (Zyrtec-D®, Virlix-D®, etc.)

Read more at Wikipedia.org


[List your site here Free!]


Wellpoint Health Networks - Supplier News - new guidelines on prescriptions Zyrtec, Allegra, and Clarinex - Brief Article
From Drug Store News, 10/7/02

Wellpoint Health Networks has implemented new guidelines on prescriptions of Pfizer s Zytrec, Aventis' Allegra and Schering-Plough's Clarinex. Wellpoint has placed the drugs in the highest co-pay tier and requires special physician approval to obtain the prescriptions. Health insurers Humana, Sierra Health Networks and UnitedHealth Group will follow Wellpoint's lead in incentivizing patients to take OTC Claritin by implementing similiar procedures, according to a news report.

In related news, Schering-Plough may not be the only loratadine OTC player come January. The U.S. District Court of New Jersey recently ruled that the exclusivity patent protecting Claritin did not extend through 2004 as Schering-Plough argued, but instead expires Dec. 19. The consumer health care divisions of both Wyeth and McNeil have each filed loratadine applications to the FDA. Schering-Plough appealed the decision.

COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2002 Gale Group

Return to Zyrtec
Home Contact Resources Exchange Links ebay